Experimental Hematology

Journal for Hematology, Stem Cell Biology and Transplantation
Official Publication of the

Experimental Hematology - ISSN 0301-472X
Source Normalized Impact per Paper (SNIP): 0.692 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 1.419 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 2.82 (2016) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
5 Year Impact Factor: 2.476 (2016) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volumes 57-68
Issues: 12 issues
ISSN: 0301472X

Personal Subscription

Tax/VAT will be calculated at check-out

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Experimental Hematology is the official Journal of the .

Experimental Hematology brings you original research articles and current, authoritative reviews on all aspects of hematology, with emphasis on the biology of normal and malignant hematopoiesis, as well as non-malignant hematologic disorders. Additionally, the journal covers submissions with clear relevance to hematology in the following topic areas: non-hematopoietic stem cells (e.g. mesenchymal stem cells, embryonic stem cells and induced pluripotent stems); translational or early phase clinical studies, disease pathogenesis or therapy; and novel techniques or animal models, genomics and systems biology analyses of hematological networks.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our .

Please see our for information on article submission. If you require any further information or help, please visit our